table of content
1 Introduction to Research & Analysis Reports
1.1 Type-1 Diabetes Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Type-1 Diabetes Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Type-1 Diabetes Treatment Overall Market Size
2.1 Global Type-1 Diabetes Treatment Market Size: 2021 VS 2028
2.2 Global Type-1 Diabetes Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Type-1 Diabetes Treatment Players in Global Market
3.2 Top Global Type-1 Diabetes Treatment Companies Ranked by Revenue
3.3 Global Type-1 Diabetes Treatment Revenue by Companies
3.4 Top 3 and Top 5 Type-1 Diabetes Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Type-1 Diabetes Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Type-1 Diabetes Treatment Players in Global Market
3.6.1 List of Global Tier 1 Type-1 Diabetes Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Type-1 Diabetes Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Type-1 Diabetes Treatment Market Size Markets, 2021 & 2028
4.1.2 Rapid-Acting Insulin
4.1.3 Short-Acting Insulin
4.1.4 Others
4.2 By Type - Global Type-1 Diabetes Treatment Revenue & Forecasts
4.2.1 By Type - Global Type-1 Diabetes Treatment Revenue, 2017-2022
4.2.2 By Type - Global Type-1 Diabetes Treatment Revenue, 2023-2028
4.2.3 By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Type-1 Diabetes Treatment Market Size, 2021 & 2028
5.1.2 Hospitals & Clinics
5.1.3 Academic & Research Institutes
5.2 By Application - Global Type-1 Diabetes Treatment Revenue & Forecasts
5.2.1 By Application - Global Type-1 Diabetes Treatment Revenue, 2017-2022
5.2.2 By Application - Global Type-1 Diabetes Treatment Revenue, 2023-2028
5.2.3 By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Type-1 Diabetes Treatment Market Size, 2021 & 2028
6.2 By Region - Global Type-1 Diabetes Treatment Revenue & Forecasts
6.2.1 By Region - Global Type-1 Diabetes Treatment Revenue, 2017-2022
6.2.2 By Region - Global Type-1 Diabetes Treatment Revenue, 2023-2028
6.2.3 By Region - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Type-1 Diabetes Treatment Revenue, 2017-2028
6.3.2 US Type-1 Diabetes Treatment Market Size, 2017-2028
6.3.3 Canada Type-1 Diabetes Treatment Market Size, 2017-2028
6.3.4 Mexico Type-1 Diabetes Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Type-1 Diabetes Treatment Revenue, 2017-2028
6.4.2 Germany Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.3 France Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.4 U.K. Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.5 Italy Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.6 Russia Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Type-1 Diabetes Treatment Market Size, 2017-2028
6.4.8 Benelux Type-1 Diabetes Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Type-1 Diabetes Treatment Revenue, 2017-2028
6.5.2 China Type-1 Diabetes Treatment Market Size, 2017-2028
6.5.3 Japan Type-1 Diabetes Treatment Market Size, 2017-2028
6.5.4 South Korea Type-1 Diabetes Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Type-1 Diabetes Treatment Market Size, 2017-2028
6.5.6 India Type-1 Diabetes Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Type-1 Diabetes Treatment Revenue, 2017-2028
6.6.2 Brazil Type-1 Diabetes Treatment Market Size, 2017-2028
6.6.3 Argentina Type-1 Diabetes Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, 2017-2028
6.7.2 Turkey Type-1 Diabetes Treatment Market Size, 2017-2028
6.7.3 Israel Type-1 Diabetes Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Type-1 Diabetes Treatment Market Size, 2017-2028
6.7.5 UAE Type-1 Diabetes Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Astellas Pharma
7.1.1 Astellas Pharma Corporate Summary
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Type-1 Diabetes Treatment Major Product Offerings
7.1.4 Astellas Pharma Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.1.5 Astellas Pharma Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Type-1 Diabetes Treatment Major Product Offerings
7.2.4 Merck Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Type-1 Diabetes Treatment Major Product Offerings
7.3.4 Eli Lilly Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Type-1 Diabetes Treatment Major Product Offerings
7.4.4 Novo Nordisk Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Type-1 Diabetes Treatment Major Product Offerings
7.5.4 Sanofi Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.5.5 Sanofi Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Type-1 Diabetes Treatment Major Product Offerings
7.6.4 AstraZeneca Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Corporate Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.7.5 Boehringer Ingelheim GmbH Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Type-1 Diabetes Treatment Major Product Offerings
7.8.4 Novartis Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.8.5 Novartis Key News
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Corporate Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Type-1 Diabetes Treatment Major Product Offerings
7.9.4 Pfizer Inc. Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.9.5 Pfizer Inc. Key News
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Corporate Summary
7.10.2 Abbott Laboratories Business Overview
7.10.3 Abbott Laboratories Type-1 Diabetes Treatment Major Product Offerings
7.10.4 Abbott Laboratories Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.10.5 Abbott Laboratories Key News
7.11 Mannkind Corporation
7.11.1 Mannkind Corporation Corporate Summary
7.11.2 Mannkind Corporation Business Overview
7.11.3 Mannkind Corporation Type-1 Diabetes Treatment Major Product Offerings
7.11.4 Mannkind Corporation Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.11.5 Mannkind Corporation Key News
7.12 Braun Melsungen AG
7.12.1 Braun Melsungen AG Corporate Summary
7.12.2 Braun Melsungen AG Business Overview
7.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Major Product Offerings
7.12.4 Braun Melsungen AG Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.12.5 Braun Melsungen AG Key News
7.13 Macrogenics, Inc.
7.13.1 Macrogenics, Inc. Corporate Summary
7.13.2 Macrogenics, Inc. Business Overview
7.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Major Product Offerings
7.13.4 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
7.13.5 Macrogenics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
